<bill session="116" type="h" number="6620" updated="2020-07-13T18:42:29Z">
  <state datetime="2020-04-24">REFERRED</state>
  <status>
    <introduced datetime="2020-04-24"/>
  </status>
  <introduced datetime="2020-04-24"/>
  <titles>
    <title type="official" as="introduced">To authorize grants to address substance use during COVID-19.</title>
    <title type="display">To authorize grants to address substance use during COVID-19.</title>
  </titles>
  <sponsor bioguide_id="K000382"/>
  <cosponsors>
    <cosponsor bioguide_id="K000386" joined="2020-04-24"/>
    <cosponsor bioguide_id="T000483" joined="2020-05-27"/>
  </cosponsors>
  <actions>
    <action datetime="2020-04-24">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-04-24" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Digestive and metabolic diseases"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="HIV/AIDS"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Mental health"/>
  </subjects>
  <amendments/>
  <summary date="2020-04-24T04:00:00Z" status="Introduced in House">This bill requires the Substance Abuse and Mental Health Services Administration (SAMHSA) to award grants to eligible jurisdictions and community-based organizations to address the harms of substance misuse, including by encouraging actions to reduce health impacts of substance use during national disasters and emergencies. SAMHSA shall prioritize grants by accounting for such factors as drug overdose death rates.</summary>
  <committee-reports/>
</bill>
